Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan · Delayed Price · Currency is TWD 35.50
-1.15 (-3.14%)
Sep 15, 2026, 1:35 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.24 billion as of September 15, 2026. Its market cap has increased by 37.18% in one year.
Market Cap
1.24B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
35.50
ChartMarket Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.24B, an increase of 11.88%. That is a compound annual growth rate of 3.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 1.24B | 12.91% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeXun Biosciences | 2.11B |
| Anti-Microbial Savior BioteQ | 1.98B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.97B |
| Sunny Pharmtech | 1.94B |
| G&E Herbal Biotechnology | 1.83B |
| Synbio Tech | 1.55B |
| Greenyn Biotechnology | 1.54B |
| TaiRx | 1.46B |